Infinity Pharmaceuticals | INFI - Operating Profit


Infinity Pharmaceuticals reported $-10.12M in Operating Profit for its fiscal quarter ending in June of 2023.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -7.89M 540K Sep/2025
CSL USD 666M 1.31B Jun/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 411.56M 15.51M Sep/2025
Incyte USD 383.88M 47.43M Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Novartis USD 4.5B 363M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025